טוען...

Optimizing drug outcomes through pharmacogenetics: A case for preemptive genotyping

Routine integration of genotype data into drug decision-making could improve patient safety, particularly if many relevant genetic variants can be assayed simultaneously before target drug prescribing. The frequency of pharmacogenetic prescribing opportunities and the potential adverse events (AE) m...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
Main Authors:	Schildcrout, Jonathan S., Denny, Joshua C., Bowton, Erica, Gregg, William, Pulley, Jill M., Basford, Melissa A., Cowan, James D., Xu, Hua, Ramirez, Andrea H., Crawford, Dana C., Ritchie, Marylyn D., Peterson, Josh F., Masys, Daniel R., Wilke, Russell A., Roden, Dan M.
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	2012
נושאים:	Article
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3785311/ https://ncbi.nlm.nih.gov/pubmed/22739144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2012.66
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Optimizing drug outcomes through pharmacogenetics: A case for preemptive genotyping

פריטים דומים